by admin | Feb 11, 2021 | Pharmaceutical Litigation, Varubi
Even investors have issues with the chemotherapy nausea drug, Varubi. They claim that the manufacturer, Tesaro artificially inflated the value of their drug. The company did this by failing to warn about risks of anaphylaxis, anaphylactic shock, and other...
Recent Comments